Verve Therapeutics Announces Inducement Grants under Nasdaq

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of...

Related Keywords

Boston ,Massachusetts ,United States ,Jen Robinson ,Verve Therapeutics Inc ,Nasdaq ,Stock Incentive Plan ,Nasdaq Listing Rule ,Verve Therapeutics ,Nasdaq Verv ,